Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
Clin Exp Med. 2024 Apr 3;24(1):67. doi: 10.1007/s10238-024-01323-1.
Colorectal cancer (CRC) is the second most prevalent cancer type worldwide, which highlights the urgent need for non-invasive biomarkers for its early detection and improved prognosis. We aimed to investigate the patterns of long non-coding RNAs (lncRNAs) in small extracellular vesicles (sEVs) collected from low-volume blood serum specimens of CRC patients, focusing on their potential as diagnostic biomarkers. Our research comprised two phases: an initial exploratory phase involving RNA sequencing of sEVs from 76 CRC patients and 29 healthy controls, and a subsequent validation phase with a larger cohort of 159 CRC patients and 138 healthy controls. Techniques such as dynamic light scattering, transmission electron microscopy, and Western blotting were utilized for sEV characterization. Optimized protocol for sEV purification, RNA isolation and preamplification was applied to successfully sequence the RNA content of sEVs and validate the results by RT-qPCR. We successfully isolated sEVs from blood serum and prepared sequencing libraries from a low amount of RNA. High-throughput sequencing identified differential levels of 460 transcripts between CRC patients and healthy controls, including mRNAs, lncRNAs, and pseudogenes, with approximately 20% being lncRNAs, highlighting several tumor-specific lncRNAs that have not been associated with CRC development and progression. The validation phase confirmed the upregulation of three lncRNAs (NALT1, AL096828, and LINC01637) in blood serum of CRC patients. This study not only identified lncRNA profiles in a population of sEVs from low-volume blood serum specimens of CRC patients but also highlights the value of innovative techniques in biomolecular research, particularly for the detection and analysis of low-abundance biomolecules in clinical samples. The identification of specific lncRNAs associated with CRC provides a foundation for future research into their functional roles in cancer development and potential clinical applications.
结直肠癌(CRC)是全球第二大常见癌症类型,这凸显了迫切需要非侵入性生物标志物来进行早期检测和改善预后。我们旨在研究从小体积血淸标本中收集的结直肠癌患者的小细胞外囊泡(sEVs)中的长非编码 RNA(lncRNA)模式,重点研究它们作为诊断生物标志物的潜力。我们的研究包括两个阶段:第一阶段涉及对 76 名 CRC 患者和 29 名健康对照者的 sEVs 的 RNA 测序,第二阶段涉及对 159 名 CRC 患者和 138 名健康对照者的更大队列进行验证。研究釆用动态光散射、透射电子显微镜和 Western 印迹等技术对 sEVs 进行表征。优化了 sEV 纯化、RNA 分离和预扩增的方案,成功地对 sEVs 的 RNA 内容进行了测序,并通过 RT-qPCR 对结果进行了验证。我们成功地从血清中分离了 sEVs,并从少量 RNA 中制备了测序文库。高通量测序鉴定出 CRC 患者与健康对照者之间存在 460 种转录物的差异水平,包括 mRNAs、lncRNAs 和假基因,其中约 20%为 lncRNAs,突出了几种与 CRC 发生和发展无关的肿瘤特异性 lncRNAs。验证阶段证实了 CRC 患者血清中三个 lncRNAs(NALT1、AL096828 和 LINC01637)的上调。这项研究不仅在 CRC 患者小体积血淸标本的 sEV 群体中鉴定了 lncRNA 图谱,还突出了创新技术在生物分子研究中的价值,特别是在临床样本中低丰度生物分子的检测和分析方面。与 CRC 相关的特定 lncRNAs 的鉴定为进一步研究它们在癌症发生和发展中的功能作用以及潜在的临床应用提供了基础。